BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 21, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

'Brutal test' shows partial protein can reverse Rett syndrome

Oct. 12, 2017
By Anette Breindl
A Gordian knot-like approach may be feasible in gene therapy for Rett syndrome. Researchers at the British University of Edinburgh have demonstrated that treating mice with a "radically truncated" gene that encoded about a third of the full-length MeCP2 protein, which is mutated in Rett syndrome, allowed the animals to survive long term with minimal symptoms.
Read More

Will multipronged Alzheimer's attack be more successful?

Oct. 11, 2017
By Anette Breindl

Will multipronged AD attack be more successful?

Oct. 11, 2017
By Anette Breindl
Claude-Henry Volmar is no longer particularly surprised when clinical trials of drugs for Alzheimer's disease (AD) fail.
Read More

Alternate circuit may yield obesity, cachexia targets

Oct. 9, 2017
By Anette Breindl

Bench Press: BioWorld looks at translational medicine

Oct. 9, 2017
By Anette Breindl
Editing the myocilin gene, the most frequently mutated gene in primary open-angle glaucoma, reduced glaucoma symptoms in an animal model. Primary open-angle glaucoma is the most frequent form of glaucoma in the U.S., affecting roughly 3 million people.
Read More

Alternate circuit may yield obesity, cachexia targets

Oct. 9, 2017
By Anette Breindl
One of the challenges for weight loss is that the body is evolutionarily programmed to worry about famines, not feasts. As a result, losing weight, if not exactly easy, is achievable for many individuals. Keeping that weight off, though, is a formidable challenge, because weight loss sets off powerful compensatory mechanisms in the body.
Read More

Crystal-clear images, no crystal required

Oct. 5, 2017
By Anette Breindl

Crystal-clear images, no crystal required

Oct. 5, 2017
By Anette Breindl
Many Nobel Prizes are awarded for conceptual advances that lead to new ways of looking at the world in a figurative sense.
Read More

Time Lords and Night Owls: Scientists awarded Nobel for circadian rhythm work

Oct. 3, 2017
By Anette Breindl

Time Lords and Night Owls: Nobel goes for circadian rhythm work

Oct. 3, 2017
By Anette Breindl
Living in Stockholm, where the length of daylight ranges from about six hours at winter solstice to 18.5 hours at midsummer, pretty much guarantees a curiosity about how internal circadian rhythms are maintained.
Read More
Previous 1 2 … 142 143 144 145 146 147 148 149 150 … 401 402 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 21, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing